4.750USDMkt Cap: 336.45M USDP/E: —Last update: 2026-05-22
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The c…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap336.45M USD
Enterprise Value3.41M USD
Revenue (TTM)510.36K USD
Gross Profit167.41K USD
Net Income (TTM)-8.31M USD
Revenue/Share0.4660 USD
Last Price4.750 USD
Fiscal Year EndDec 2024
MR QuarterDec 2024
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.51
EV/Revenue6.68
P/S627.32
P/B0.99
EPS (TTM)-0.12
EPS (Forward)—
52W Range
4.500100% of range4.750
52W High4.750 USD
52W Low4.500 USD
Profitability
Gross Margin28.05%
Oper. Margin-444.59%
EBITDA Margin-265.93%
Profit Margin-1392.61%
ROE291.05%
ROA-60.32%
Growth
Revenue Growth95.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.60M USD
CapEx (TTM)1.44M USD
FCF Margin-759.38%
FCF Yield-1.15%
Net Debt-3.11M USD
Net Debt/EBITDA2.29
Balance Sheet
Debt/Equity-0.00
Current Ratio13.18
Quick Ratio12.91
Book Value/Sh4.571 USD
Cash/Share2.173 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.70.83M
Float319.87K
Insiders81.01%
Institutions0.49%
Short Interest
Short Ratio0.9d
Short % Float0.13%
Short % Out.0.03%
Shares Short21.86K
Short (prev mo.)24.80K
Technical
SMA 505.953 (-20.2%)
SMA 20011.09 (-57.2%)
Beta-0.06
S&P 52W Chg28.31%
Avg Vol (30d)4.45K
Avg Vol (10d)6.01K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—